Verdence Capital Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$479K Buy
4,062
+260
+7% +$36.3K 0.03% 437
2025
Q4
$623K Sell
3,802
-1,108
-23% -$174K 0.04% 366
2025
Q3
$791K Buy
4,910
+215
+5% +$26.1K 0.05% 338
2025
Q2
$584K Buy
4,695
+362
+8% +$46.1K 0.04% 367
2025
Q1
$551K Buy
4,333
+480
+12% +$73.9K 0.04% 351
2024
Q4
$555K Buy
3,853
+45
+1% +$6.45K 0.04% 340
2024
Q3
$567K Buy
3,808
+651
+21% +$93.3K 0.05% 345
2024
Q2
$398K Sell
3,157
-5
-0.2% -$784 0.04% 387
2024
Q1
$582K Buy
3,162
+206
+7% +$39.2K 0.05% 323
2023
Q4
$531K Buy
2,956
+793
+37% +$123K 0.05% 326
2023
Q3
$344K Buy
2,163
+135
+7% +$22.1K 0.04% 396
2023
Q2
$287K Buy
+2,028
New +$325K 0.03% 426

Other funds holding RGEN

Verdence Capital Advisors's RGEN Position: Q1 2026 in Review

Verdence Capital Advisors increased its Repligen (RGEN) stake by 6.8% in Q1 2026, buying an estimated $36.3K and bringing the position to 4,062 shares worth $479K. The position accounts for 0.03% of the portfolio, ranked #437.

Verdence Capital Advisors first reported a position in RGEN in Q2 2023 and has held it in 12 quarters since. The position peaked at $791K in Q3 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Verdence Capital Advisors held 4,062 shares of Repligen worth $479K as of Q1 2026.
  • Verdence Capital Advisors bought 260 Repligen shares in Q1 2026, an estimated $36.3K.
  • Repligen made up 0.03% of Verdence Capital Advisors's portfolio in Q1 2026, its #437 holding.
  • Verdence Capital Advisors first reported a position in Repligen in Q2 2023 and has held it in 12 quarters since.
  • Verdence Capital Advisors's Repligen position peaked at $791K in Q3 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Verdence Capital Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.